167 related articles for article (PubMed ID: 15659058)
1. Inherited cardiac arrhythmia syndromes: what have they taught us about arrhythmias and anti-arrhythmic therapy?
Subbiah RN; Campbell TJ; Vandenberg JI
Clin Exp Pharmacol Physiol; 2004 Dec; 31(12):906-12. PubMed ID: 15659058
[TBL] [Abstract][Full Text] [Related]
2. Pharmacotherapy for inherited arrhythmia syndromes: mechanistic basis, clinical trial evidence and practical application.
Tadros R; Cadrin-Tourigny J; Abadir S; Rivard L; Nattel S; Talajic M; Khairy P
Expert Rev Cardiovasc Ther; 2015; 13(7):769-82. PubMed ID: 25994014
[TBL] [Abstract][Full Text] [Related]
3. [HERG K+ channel, the target of anti-arrhythmias drugs].
Guan FY; Yang SJ
Yao Xue Xue Bao; 2007 Jul; 42(7):687-91. PubMed ID: 17882949
[TBL] [Abstract][Full Text] [Related]
4. Pharmacogenetics and cardiac ion channels.
Roepke TK; Abbott GW
Vascul Pharmacol; 2006 Feb; 44(2):90-106. PubMed ID: 16344000
[TBL] [Abstract][Full Text] [Related]
5. Sodium channels as macromolecular complexes: implications for inherited arrhythmia syndromes.
Meadows LS; Isom LL
Cardiovasc Res; 2005 Aug; 67(3):448-58. PubMed ID: 15919069
[TBL] [Abstract][Full Text] [Related]
6. Drug-induced fatal arrhythmias: Acquired long QT and Brugada syndromes.
Turker I; Ai T; Itoh H; Horie M
Pharmacol Ther; 2017 Aug; 176():48-59. PubMed ID: 28527921
[TBL] [Abstract][Full Text] [Related]
7. Disopyramide is an effective inhibitor of mutant HERG K+ channels involved in variant 1 short QT syndrome.
McPate MJ; Duncan RS; Witchel HJ; Hancox JC
J Mol Cell Cardiol; 2006 Sep; 41(3):563-6. PubMed ID: 16842817
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic manifestations of mutations in genes encoding subunits of cardiac potassium channels.
Shimizu W; Horie M
Circ Res; 2011 Jun; 109(1):97-109. PubMed ID: 21700951
[TBL] [Abstract][Full Text] [Related]
9. hERG potassium channels and cardiac arrhythmia.
Sanguinetti MC; Tristani-Firouzi M
Nature; 2006 Mar; 440(7083):463-9. PubMed ID: 16554806
[TBL] [Abstract][Full Text] [Related]
10. Short QT-a silent harbinger of lethal arrhythmias.
Majumder B; Kumar A
Indian Heart J; 2008; 60(6):584-7. PubMed ID: 19276501
[No Abstract] [Full Text] [Related]
11. Short QT syndrome. What is it? Where is it?
Puri VK; Dwivedi SK; Puri A; Behal K
Indian Heart J; 2005; 57(6):769-71. PubMed ID: 16521657
[No Abstract] [Full Text] [Related]
12. The hERG K+ channel: target and antitarget strategies in drug development.
Raschi E; Vasina V; Poluzzi E; De Ponti F
Pharmacol Res; 2008 Mar; 57(3):181-95. PubMed ID: 18329284
[TBL] [Abstract][Full Text] [Related]
13. [Short QT Syndromes].
Schulze-Bahr E
Herz; 2006 Apr; 31(2):118-22; quiz 142-3. PubMed ID: 16738834
[TBL] [Abstract][Full Text] [Related]
14. In vivo effects of mutant HERG K+ channel inhibition by disopyramide in patients with a short QT-1 syndrome: a pilot study.
Schimpf R; Veltmann C; Giustetto C; Gaita F; Borggrefe M; Wolpert C
J Cardiovasc Electrophysiol; 2007 Nov; 18(11):1157-60. PubMed ID: 17711440
[TBL] [Abstract][Full Text] [Related]
15. Short QT syndrome.
Brugada R; Hong K; Cordeiro JM; Dumaine R
CMAJ; 2005 Nov; 173(11):1349-54. PubMed ID: 16301704
[TBL] [Abstract][Full Text] [Related]
16. [Failure of antiarrhythmia agents and understanding the phenomenon of proarrhythmia].
Semrád B
Vnitr Lek; 2003 Sep; 49(9):700-6. PubMed ID: 14584417
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing in the management of inherited arrhythmia syndromes.
Tzou WS; Gerstenfeld EP
Curr Cardiol Rep; 2009 Sep; 11(5):343-51. PubMed ID: 19709494
[TBL] [Abstract][Full Text] [Related]
18. Anti-HERG activity and the risk of drug-induced arrhythmias and sudden death.
De Bruin ML; Pettersson M; Meyboom RH; Hoes AW; Leufkens HG
Eur Heart J; 2005 Mar; 26(6):590-7. PubMed ID: 15637086
[TBL] [Abstract][Full Text] [Related]
19. Electromechanical window negativity in genotyped long-QT syndrome patients: relation to arrhythmia risk.
ter Bekke RM; Haugaa KH; van den Wijngaard A; Bos JM; Ackerman MJ; Edvardsen T; Volders PG
Eur Heart J; 2015 Jan; 36(3):179-86. PubMed ID: 25205533
[TBL] [Abstract][Full Text] [Related]
20. Clinical Features of Genetic Cardiac Diseases Related to Potassium Channelopathies.
Adler A; Viskin S
Card Electrophysiol Clin; 2016 Jun; 8(2):361-72. PubMed ID: 27261827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
